Fig. 1
From: CuO nanoparticles for glioma treatment in vitro and in vivo

Characterization of CuO NPs. (a) TEM topography, (b) statistical distribution of CuO NPs particle size in TEM, and (c) XRD pattern of CuO NPs.
From: CuO nanoparticles for glioma treatment in vitro and in vivo

Characterization of CuO NPs. (a) TEM topography, (b) statistical distribution of CuO NPs particle size in TEM, and (c) XRD pattern of CuO NPs.